Drinking caffeinated coffee has both beneficial and harmful short-term health effects
Research Highlights:
- A randomized trial to study caffeinated coffee consumption among 100 volunteers for two weeks found both potentially beneficial and harmful short-term health consequences of drinking coffee.
- When participants were randomly assigned to drink coffee, they were more physically active, yet they also […]
Fatal heart attack or stroke could be first sign of CVD in some smokers Journal of the American Heart Association Report
Research Highlights:
- Years of research have linked cigarette smoking to premature illness and death from multiple conditions including CVD. However, a new study found that dying of a heart attack or stroke may often be the first sign of CVD in some people […]
Stroke survivors less likely than cancer survivors to have quit smoking, says new study
Research Highlights:
- Almost 40% of stroke survivors who smoked cigarettes before their stroke continue to smoke, a rate that hasn’t decreased in recent decades, according to a new study analyzing national survey data.
- Stroke survivors with a history of smoking were 28% less likely […]
Novel algorithm on wearable devices can detect irregular heartbeat, may prompt early care
Research Highlights:
- A novel software algorithm developed for wearable devices, such as smartwatches and fitness trackers, was able to detect irregular heart rhythms.
- Analysis of heartbeat data for nearly half a million wearable-device users found that the algorithm was able to accurately detect irregular […]
-
Prescription omega-3 pill didn’t affect outcome for non-hospitalized adults with COVID-19 American Heart Association Scientific Sessions 2021, LBS .06 GalleryPrescription omega-3 pill didn’t affect outcome for non-hospitalized adults with COVID-19 American Heart Association Scientific Sessions 2021, LBS .06
Prescription omega-3 pill didn’t affect outcome for non-hospitalized adults with COVID-19 American Heart Association Scientific Sessions 2021, LBS .06
Research Highlights:
- Adults with COVID-19 infection who were not hospitalized received a prescription strength, purified omega-3 fatty acid to determine if it might reduce their chance of hospitalization or death.
- The purified omega-3 fatty acid, icosapent ethyl, did not result in a statistically significant […]
-
Oral PCSK9 inhibitor found to be safe, effective to lower cholesterol, in first human trial American Heart Association Scientific Sessions 2021, LBS.06 GalleryOral PCSK9 inhibitor found to be safe, effective to lower cholesterol, in first human trial American Heart Association Scientific Sessions 2021, LBS.06
Oral PCSK9 inhibitor found to be safe, effective to lower cholesterol, in first human trial American Heart Association Scientific Sessions 2021, LBS.06
Research Highlights:
- Two studies report the safety and effectiveness of MK-0616, a new cholesterol-lowering medicine in a class of drugs called PCSK9 inhibitors. MK-0616 is taken by mouth, as opposed to injection like currently available PCSK9 inhibitors.
- Men who received once-daily doses of up […]
-
Long-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes American Heart Association Scientific Sessions 2021, LBS.07 GalleryLong-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes American Heart Association Scientific Sessions 2021, LBS.07
Long-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes American Heart Association Scientific Sessions 2021, LBS.07
Research Highlights:
- Daily low-dose aspirin taken for an average of seven years did not affect the risk of dementia in adults with type 2 diabetes.
- The aspirin regimen was neither protective nor harmful regarding dementia risk.
- A heart attack or stroke was associated with at […]
Monitoring for individual triggers may reduce episodes of atrial fibrillation – American Heart Association Scientific Sessions 2021, LBS.04
Research Highlights:
- Personalized testing may help identify triggers for irregular heart rhythms and reduce their frequency in people with atrial fibrillation.
- Alcohol consumption was linked to having an atrial fibrillation episode.
- Caffeine did not appear to increase the risk for an episode of atrial fibrillation.
Embargoed […]
-
Heart failure symptoms improved with a type 2 diabetes medicine in fully remote trial – American Heart Association Scientific Sessions 2021, LBS.05 GalleryHeart failure symptoms improved with a type 2 diabetes medicine in fully remote trial – American Heart Association Scientific Sessions 2021, LBS.05
Heart failure symptoms improved with a type 2 diabetes medicine in fully remote trial – American Heart Association Scientific Sessions 2021, LBS.05
Research Highlights:
- Adults with heart failure who took canagliflozin, a medication originally developed to treat type 2 diabetes, reported improvements in their heart failure symptoms whether or not they also had type 2 diabetes.
- Symptom and quality of life benefits were evident as early […]
-
Adults with acute heart failure benefit when treated with a type 2 diabetes medication – American Heart Association Scientific Sessions 2021, LBS.05 GalleryAdults with acute heart failure benefit when treated with a type 2 diabetes medication – American Heart Association Scientific Sessions 2021, LBS.05
Adults with acute heart failure benefit when treated with a type 2 diabetes medication – American Heart Association Scientific Sessions 2021, LBS.05
Research Highlights:
- When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical benefit, such as a reduction in all-cause mortality, reduction in heart failure events, or an improvement in heart failure symptoms.
- Empagliflozin was originally primarily […]